Tactile Systems Technology, Inc. (NASDAQ: TCMD) reported Q4 EPS of $0.12, $0.01 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $34.9 million versus the consensus estimate of $33.76 million.

Fourth Quarter 2017 Summary:

• Net income for the fourth quarter of 2017 decreased $0.1 million, or 6%, to $2.2 million, or $0.12 per diluted share, compared to $2.4 million, or $0.13 per diluted share, in the fourth quarter of 2016. Weighted average shares used to compute diluted net income per share were 19.1 million and 18.7 million for the fourth quarters of 2017 and 2016, respectively.
• Fourth quarter revenues increased 23% year-over-year, to $34.9 million, compared to $28.5 million in fourth quarter 2016.
• Flexitouch revenues increased 28% year-over-year, to $32.4 million, compared to $25.4 million in fourth quarter 2016.
• Operating income of $4.9 million, compared to operating income of $3.3 million in fourth quarter 2016.
• Net income of $2.2 million, compared to net income of $2.4 million in fourth quarter 2016.
• Adjusted EBITDA of $6.8 million compared to $4.4 million in fourth quarter 2016.
• On December 7, 2017 the Company announced the publication of a functional use study in the medical journal “Head & Neck” that assessed the Company’s Flexitouch system for the treatment of lymphedema of the head and neck. Researchers concluded that Flexitouch is safe, easy to use, and well tolerated, while demonstrating edema reduction after a single 32 minute treatment session.

2018 Financial Outlook

For 2018, the Company expects revenues in the range of $131 million to $133 million, representing growth of 20% to 22% year-over-year, compared to revenues of $109.3 million in 2017.

GUIDANCE:

Tactile Systems Technology, Inc. sees FY2018 revenue of $131-133 million, versus the consensus of $131.13 million.

For earnings history and earnings-related data on Tactile Systems Technology, Inc. (TCMD) click here.